However, unique features of osteosarcoma in dogs, such as mutations in the epigenetic regulator, SETD2, and deletions in DMD, the gene encoding dystrophin, may help explain the more aggressive disease biology recognized in canine osteosarcoma (Perry et al. Here, DMD is linked to osteosarcoma.